GO:0042182 ketone catabolic process: Metabolic Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042182 (ketone catabolic process) describes the biochemical breakdown of ketone bodies such as acetoacetate and beta-hydroxybutyrate into acetyl-CoA for energy production.
• The pathway is essential for metabolic flexibility during fasting, ketogenic diets, and intermittent time-restricted feeding, supporting skeletal and cardiac muscle remodeling.
• BDH1 catalyzes the reversible oxidation of beta-hydroxybutyrate to acetoacetate, a rate-limiting step in ketone catabolism.
• OXCT1 (SCOT) mediates the rate-limiting transfer of CoA from succinyl-CoA to acetoacetate, committing ketone bodies to terminal oxidation.
• Altered ketone catabolism contributes to heart failure, diabetic cardiomyopathy, and obesity-related hyperglycemia.
• CRISPR knockout, knock-in, and overexpression models are powerful tools to dissect the causal roles of BDH1, OXCT1, and ACAT1 in ketone catabolic flux.
Description
Ketone bodies are water-soluble, lipid-derived molecules that serve as alternative fuels when glucose availability is low. The Gene Ontology term GO:0042182, ketone catabolic process, captures the chemical reactions and pathways that result in the breakdown of ketones, a class of organic compounds containing a carbonyl group bonded only to carbon atoms. In mammalian physiology, this process primarily refers to the mitochondrial oxidation of beta-hydroxybutyrate and acetoacetate into acetyl-CoA, which then enters the tricarboxylic acid cycle to generate ATP. Understanding ketone catabolism is critical because it underpins metabolic flexibility in skeletal muscle, cardiac muscle, and other oxidative tissues. Research has shown that ketone flux through BDH1 supports metabolic remodeling of skeletal and cardiac muscles in response to intermittent time-restricted feeding. In heart failure, myocardial ketone metabolism is altered, and modulating ketone oxidation can influence cardiac substrate utilization and mitochondrial redox. Moreover, inhibiting skeletal muscle ketone oxidation with pimozide alleviates hyperglycemia in diet-induced obesity, highlighting the therapeutic potential of targeting this pathway. This article provides a research-grade overview of GO:0042182, covering its definition, molecular mechanisms, key genes, disease relevance, and state-of-the-art methods including CRISPR-based models. All statements are grounded in peer-reviewed literature to support researchers, clinicians, and AI-driven knowledge retrieval systems.
ketone catabolic process At A Glance
| GO ID | GO:0042182 |
|---|---|
| GO term | ketone catabolic process |
| Ontology | biological_process |
| Synonym | ketone breakdown, ketone catabolism, ketone degradation |
| Major function | Breakdown of ketone bodies into acetyl-CoA for energy production |
| Key enzymes | BDH1, OXCT1, ACAT1 |
| Subcellular location | Mitochondrial matrix |
| Physiological context | Fasting, ketogenic diet, intermittent time-restricted feeding, exercise |
What Is GO:0042182?
GO:0042182, ketone catabolic process, is defined by the Gene Ontology as the chemical reactions and pathways resulting in the breakdown of ketones, a class of organic compounds that contain the carbonyl group (CO) and in which the carbonyl group is bonded only to carbon atoms. The general formula for a ketone is RCOR, where R and R are alkyl or aryl groups. In biological systems, this term encompasses the enzymatic steps that convert ketone bodies, such as beta-hydroxybutyrate and acetoacetate, into acetyl-CoA and other metabolites for energy production.
Why Is ketone catabolic process Important in Cell Biology?
Ketone catabolic process is central to metabolic homeostasis, enabling tissues such as skeletal muscle, cardiac muscle, and brain to use ketone bodies as alternative fuels when glucose is scarce. Dysregulation of this pathway is implicated in heart failure, diabetic cardiomyopathy, obesity, and hyperglycemia. Targeting ketone oxidation enzymes, particularly BDH1 and OXCT1, offers therapeutic opportunities for metabolic and cardiovascular diseases. Furthermore, ketone catabolism influences mitochondrial redox balance and substrate utilization, making it a key area for understanding metabolic remodeling in health and disease.
• Supports energy production during fasting and ketogenic states.
• Facilitates metabolic flexibility in skeletal and cardiac muscle.
• Modulates mitochondrial redox and substrate utilization in heart failure.
• Inhibition of skeletal muscle ketone oxidation alleviates hyperglycemia in obesity.
• Plays a role in cardiac substrate selection and ATP generation.
• Provides acetyl-CoA for the TCA cycle and oxidative phosphorylation.
• Implicated in diabetic cardiomyopathy and heart failure progression.
• Potential target for SGLT2 inhibitor-mediated metabolic benefits.
• Relevant to exercise physiology and intermittent time-restricted feeding.
• Offers a therapeutic avenue for obesity and insulin resistance.
What Happens During ketone catabolic process?
Uptake and Activation of Ketone Bodies
In simple terms: Ketone bodies enter the cell and are prepared for breakdown.
Ketone bodies, primarily beta-hydroxybutyrate and acetoacetate, are taken up by tissues such as skeletal muscle and heart. Beta-hydroxybutyrate is oxidized to acetoacetate by BDH1 in a reversible reaction that generates NADH. This step is crucial for channeling ketone bodies into the catabolic pathway.
CoA Transfer and Acetoacetyl-CoA Formation
In simple terms: A CoA group is transferred to acetoacetate to form acetoacetyl-CoA.
OXCT1 (also known as SCOT) catalyzes the rate-limiting transfer of CoA from succinyl-CoA to acetoacetate, yielding acetoacetyl-CoA and succinate. This reaction commits ketone bodies to terminal oxidation and is essential for ketone catabolism in extrahepatic tissues.
Thiolysis to Acetyl-CoA
In simple terms: Acetoacetyl-CoA is split into two acetyl-CoA molecules.
ACAT1 (mitochondrial acetoacetyl-CoA thiolase) cleaves acetoacetyl-CoA into two molecules of acetyl-CoA. These acetyl-CoA units enter the TCA cycle, producing reducing equivalents for oxidative phosphorylation and ATP generation.
Integration with Mitochondrial Energy Metabolism
In simple terms: The breakdown products feed into the energy-producing machinery.
The acetyl-CoA generated from ketone catabolism is oxidized in the TCA cycle, driving mitochondrial respiration and ATP synthesis. This integration supports metabolic remodeling in skeletal and cardiac muscle during intermittent time-restricted feeding and heart failure.
Regulation by Substrate Availability and Hormonal Signals
In simple terms: The pathway turns on when ketone levels rise and glucose is low.
Ketone catabolic flux is regulated by substrate availability, hormonal signals such as insulin and glucagon, and the expression of BDH1 and OXCT1. SGLT2 inhibition alters substrate utilization and mitochondrial redox, indirectly influencing ketone oxidation in the heart.
Key Genes Involved in GO:0042182 ketone catabolic process
The following genes encode enzymes and regulators directly involved in ketone catabolic process, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| BDH1 | Catalyzes oxidation of beta-hydroxybutyrate to acetoacetate | Rate-limiting in ketone catabolism; target in muscle metabolic remodeling |
| OXCT1 | Transfers CoA from succinyl-CoA to acetoacetate | Essential for ketone oxidation; inhibited by pimozide in obesity |
| ACAT1 | Cleaves acetoacetyl-CoA into two acetyl-CoA | Links ketone catabolism to TCA cycle |
| HMGCS2 | Ketogenesis enzyme; not directly catabolic but regulates ketone levels | Context for ketone catabolism studies |
| SLC16A1 | Monocarboxylate transporter for ketone body uptake | Facilitates ketone entry into cells |
| SLC16A7 | Monocarboxylate transporter for ketone body uptake | Facilitates ketone entry into cells |
| PPARA | Regulates fatty acid and ketone metabolism genes | Transcriptional control of ketone catabolism |
| PGC1A | Mitochondrial biogenesis and oxidative metabolism | Supports ketone oxidation capacity |
| AMPK | Energy sensor regulating metabolic pathways | Modulates ketone catabolism during energy stress |
| SIRT1 | Deacetylase regulating mitochondrial function | May influence ketone oxidation |
| SIRT3 | Mitochondrial deacetylase | Regulates ketone catabolic enzymes |
| FOXO1 | Transcription factor in metabolic regulation | Potential regulator of ketone catabolism |
| mTOR | Nutrient sensor | Influences ketone metabolism indirectly |
| INSR | Insulin receptor | Hormonal regulation of ketone catabolism |
| ADIPOQ | Adiponectin | Linked to ketone metabolism in obesity |
| LEP | Leptin | Regulates energy balance and ketone levels |
| SLC2A4 | GLUT4 glucose transporter | Glucose-ketone substrate competition |
| PDK4 | Pyruvate dehydrogenase kinase | Influences substrate selection |
How Is ketone catabolic process Regulated?
Ketone catabolic process is regulated at multiple levels. Substrate availability, particularly beta-hydroxybutyrate and acetoacetate concentrations, directly controls flux through BDH1 and OXCT1. Hormonal signals such as insulin suppress ketone oxidation, while glucagon and low glucose promote it. Transcriptional regulators including PPARA and PGC1A enhance the expression of ketone catabolic enzymes during fasting or ketogenic conditions. Additionally, SGLT2 inhibition alters substrate utilization and mitochondrial redox, indirectly modulating ketone oxidation in the heart. Post-translational modifications, such as acetylation by SIRT3, may also influence enzyme activity.
ketone catabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| BDH1 | Heart failure, metabolic remodeling | Cardiac-specific KO mouse |
| OXCT1 | Obesity, hyperglycemia | Skeletal muscle-specific KO mouse |
| ACAT1 | Diabetic cardiomyopathy | Inducible KO in cardiomyocytes |
| SLC16A1 | Ketone transport defects | Knock-in of transport-deficient mutant |
| PPARA | Metabolic syndrome | Liver-specific overexpression |
Heart Failure and Diabetic Cardiomyopathy
Myocardial ketone metabolism is altered in heart failure, where the heart shifts substrate utilization toward ketone bodies. SGLT2 inhibition alters substrate utilization and mitochondrial redox in healthy and failing rat hearts, suggesting that ketone catabolism contributes to cardiac metabolic remodeling. Targeting ketone oxidation enzymes may improve cardiac function in heart failure.
Obesity and Hyperglycemia
Inhibiting skeletal muscle ketone oxidation with pimozide alleviates hyperglycemia in diet-induced obesity, demonstrating that ketone catabolism is causally linked to glucose homeostasis. This positions BDH1 and OXCT1 as potential therapeutic targets for obesity and type 2 diabetes.
Skeletal Muscle Wasting and Metabolic Remodeling
Semaglutide-induced loss of skeletal muscle mass is blunted by co-administration of ketone esters, indicating that ketone metabolism supports muscle preservation. Ketone flux through BDH1 supports metabolic remodeling of skeletal and cardiac muscles in response to intermittent time-restricted feeding.
From ketone catabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does BDH1 loss impair cardiac ketone oxidation? | BDH1 knockout mouse (cardiac-specific) |
| Does OXCT1 inhibition improve hyperglycemia? | OXCT1 point-mutation knock-in mouse |
| Can ketone esters rescue muscle wasting? | Overexpression of BDH1 in skeletal muscle |
| How does ACAT1 flux affect TCA cycle? | ACAT1 tagged knock-in for proteomics |
| Does SLC16A1 mediate ketone uptake? | SLC16A1 knockout cell line |
| What is the role of PPARA in ketone catabolism? | PPARA overexpression hepatocytes |
How to Study the ketone catabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C-ketone tracing | Ketone oxidation flux | Metabolic phenotyping |
| BDH1 activity assay | Enzyme activity | Tissue ketogenic capacity |
| OXCT1 activity assay | Enzyme activity | Ketone oxidation rate |
| RNA-seq | Gene expression | Transcriptional regulation |
| Proteomics | Protein abundance | Enzyme levels |
| Echocardiography | Cardiac function | Heart failure models |
| PET imaging | Substrate utilization | In vivo cardiac metabolism |
| Seahorse respirometry | Mitochondrial respiration | Cellular ketone oxidation |
Metabolic Flux Analysis
Isotope tracing with 13C-labeled ketone bodies combined with mass spectrometry measures ketone catabolic flux into the TCA cycle. This method quantifies the contribution of ketone oxidation to acetyl-CoA production in tissues.
Enzyme Activity Assays
Spectrophotometric assays for BDH1 and OXCT1 activity in tissue lysates or isolated mitochondria provide direct measures of ketone catabolic capacity. These assays are used to validate genetic models and pharmacological interventions.
Transcriptomics and Proteomics
RNA-seq and proteomics identify expression changes in ketone catabolic genes under fasting, ketogenic diet, or disease conditions. These approaches reveal regulatory networks involving PPARA, PGC1A, and SIRT3.
Cardiac Function and Imaging
Echocardiography and PET imaging with ketone tracers assess cardiac substrate utilization and function in heart failure models. These methods link ketone catabolism to cardiac performance.
How CRISPR Can Be Used to Study GO:0042182 ketone catabolic process
Knockout
CRISPR knockout of BDH1 or OXCT1 in cell lines or animal models abolishes ketone catabolic flux, enabling causal studies of their roles in metabolic remodeling and disease. Knockout models are essential for validating therapeutic targets.
Point Mutation
Point mutations in catalytic residues of BDH1 or OXCT1 can dissociate enzyme activity from scaffolding functions, providing mechanistic insights into ketone catabolism. These models help identify specific residues critical for substrate binding.
Knock-in
Knock-in of tagged BDH1 or OXCT1 allows real-time tracking of enzyme localization and interactions in mitochondria. This approach is valuable for studying dynamic regulation of ketone catabolism.
Overexpression
Overexpression of BDH1 or OXCT1 in skeletal muscle or heart enhances ketone oxidation capacity and can protect against metabolic stress. Overexpression models are used to test sufficiency of ketone catabolism in disease rescue.
How EDITGENE Supports ketone catabolic process Research
Researchers studying ketone catabolic process-related genes often need to determine whether a candidate gene is causally involved in metabolic remodeling, substrate utilization, or disease progression. EDITGENE provides end-to-end CRISPR solutions to generate precisely engineered cell and animal models, accelerating functional validation of BDH1, OXCT1, ACAT1, and other pathway components.
Contact EDITGENE today to design your custom CRISPR model for ketone catabolic process research.
Frequently Asked Questions About ketone catabolic process
What is ketone catabolic process?
Ketone catabolic process (GO:0042182) is the set of biochemical reactions that break down ketone bodies, such as beta-hydroxybutyrate and acetoacetate, into acetyl-CoA for energy production.
What genes are involved in ketone catabolic process?
Key genes include BDH1, OXCT1, and ACAT1, which encode enzymes that catalyze the steps of ketone body oxidation.
Where does ketone catabolism occur in the cell?
Ketone catabolism primarily occurs in the mitochondrial matrix, where BDH1, OXCT1, and ACAT1 are localized.
How is ketone catabolic process regulated?
It is regulated by substrate availability, hormones such as insulin and glucagon, and transcriptional regulators like PPARA and PGC1A.
What diseases are associated with ketone catabolism?
Altered ketone catabolism is linked to heart failure, diabetic cardiomyopathy, obesity, and hyperglycemia.
Can ketone catabolism be targeted therapeutically?
Yes, inhibiting skeletal muscle ketone oxidation with pimozide alleviates hyperglycemia in obesity, suggesting therapeutic potential.
What is the role of BDH1 in ketone catabolism?
BDH1 catalyzes the reversible oxidation of beta-hydroxybutyrate to acetoacetate, a rate-limiting step in ketone catabolism.
How does OXCT1 function in ketone breakdown?
OXCT1 transfers CoA from succinyl-CoA to acetoacetate, committing ketone bodies to terminal oxidation.
What methods are used to study ketone catabolic process?
Common methods include 13C-ketone tracing, enzyme activity assays, RNA-seq, proteomics, and cardiac imaging.
How can CRISPR help study ketone catabolism?
CRISPR knockout, knock-in, and overexpression models enable causal studies of BDH1, OXCT1, and ACAT1 in metabolic and cardiovascular diseases.
Conclusion
GO:0042182 ketone catabolic process is a fundamental metabolic pathway that enables tissues to utilize ketone bodies for energy, particularly during fasting, ketogenic diets, and metabolic stress. Its dysregulation is implicated in heart failure, obesity, and hyperglycemia, making it a promising therapeutic target. Advances in CRISPR-based models and metabolic flux analysis continue to unravel the precise roles of BDH1, OXCT1, and ACAT1 in health and disease. EDITGENE supports this research with comprehensive CRISPR services, from knockout and knock-in models to library screening and bioinformatics, empowering scientists to dissect ketone catabolic process with precision and speed.
References
- 3. Williams AS et al.. 2024. Ketone flux through BDH1 supports metabolic remodeling of skeletal and cardiac muscles in response to intermittent time-restricted feeding.. Cell Metab 36(2):422-437.e8 PMID: 38325337
- 4. Goedeke L et al.. 2024. SGLT2 inhibition alters substrate utilization and mitochondrial redox in healthy and failing rat hearts.. J Clin Invest 134(24) PMID: 39680452
- 5. Abuetabh Y et al.. 2026. Semaglutide-induced loss of skeletal muscle mass is blunted by co-administration of ketone esters.. JCI Insight 11(15) PMID: 42262870
- 6. Lopaschuk GD et al.. 2023. Ketones and the cardiovascular system.. Nat Cardiovasc Res 2(5):425-437 PMID: 39196044
- 7. Al Batran R et al.. 2020. Pimozide Alleviates Hyperglycemia in Diet-Induced Obesity by Inhibiting Skeletal Muscle Ketone Oxidation.. Cell Metab 31(5):909-919.e8 PMID: 32275862
- 8. Karwi QG et al.. 2020. Myocardial Ketones Metabolism in Heart Failure.. J Card Fail 26(11):998-1005 PMID: 32442517
